Olfr524 Inhibitors
Olfr524, a member of the G protein-coupled receptor family, plays a pivotal role in olfactory signal transduction, contributing to the intricate process of odor perception. Located on olfactory sensory neurons, Olfr524 functions as a molecular switch that, upon binding to specific odorants, initiates a cascade of intracellular events leading to the generation of neuronal signals and the perception of distinct smells. Its functional significance lies in the exquisite sensitivity and specificity it imparts to the olfactory system.
Inhibition of Olfr524 involves a sophisticated interplay of mechanisms, encompassing both direct and indirect approaches. Direct inhibitors, exemplified by Staurosporine, target the receptor itself, disrupting phosphorylation events and impeding the normal olfactory signal transduction process. Indirect inhibitors, such as those affecting the PI3K or p38 MAPK pathways, modulate intracellular signaling dynamics, impacting olfactory receptor neuron function and hindering the activation of Olfr524. Calcium chelation, lipid composition alteration, and interference with vesicular dynamics further contribute to the repertoire of mechanisms employed for Olfr524 inhibition. Understanding these intricate processes provides valuable insights into the regulatory mechanisms governing olfactory responses, enhancing our comprehension of sensory biology.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Acts as a direct inhibitor of Olfr524 by targeting protein kinases. Staurosporine interferes with phosphorylation events, disrupting the olfactory signal transduction process and leading to the inhibition of Olfr524. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Targets the PI3K pathway to indirectly inhibit Olfr524. LY294002 modulates intracellular signaling, impacting olfactory receptor neuron function and hindering the activation of Olfr524. The inhibition is achieved through disruption of the phosphorylation cascades associated with PI3K signaling. | ||||||
Tyrphostin AG 1478 | 175178-82-2 | sc-200613 sc-200613A | 5 mg 25 mg | $96.00 $421.00 | 16 | |
Indirectly inhibits Olfr524 by targeting the epidermal growth factor receptor (EGFR) pathway. AG1478 disrupts downstream signaling, impacting olfactory receptor neuron function and suppressing the activation of Olfr524. The inhibition is achieved through interference with the phosphorylation cascades associated with EGFR signaling. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Modulates Olfr524 indirectly by targeting the PI3K pathway. Wortmannin modifies intracellular signaling, impacting olfactory receptor neuron function and hindering the activation of Olfr524. The inhibition is achieved through disruption of the phosphorylation cascades associated with PI3K signaling. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Targets the p38 MAPK pathway to indirectly inhibit Olfr524. SB203580 blocks phosphorylation cascades, disrupting downstream signaling and suppressing olfactory signal transduction. The inhibition is achieved by interfering with the normal activation events associated with the p38 MAPK pathway. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $458.00 | 61 | |
Indirectly inhibits Olfr524 by chelating intracellular calcium, modulating olfactory receptor neuron responses. BAPTA-AM alters the olfactory signal transduction process, leading to the suppression of Olfr524 activation. The inhibition is achieved through interference with intracellular calcium dynamics critical for olfactory signal transduction. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
An inhibitor of endoplasmic reticulum (ER) Ca2+-ATPase, Thapsigargin directly affects Olfr524 activation. By disrupting ER calcium homeostasis, it interferes with the intracellular signaling required for normal olfactory signal transduction, leading to the inhibition of Olfr524. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Indirectly inhibits Olfr524 by targeting the extracellular signal-regulated kinase (ERK) pathway. PD98059 disrupts phosphorylation cascades, impacting olfactory receptor neuron function and suppressing the activation of Olfr524. The inhibition is achieved through interference with the normal activation events associated with the ERK pathway. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Affects Olfr524 indirectly by disrupting the Golgi apparatus function. Brefeldin A interferes with intracellular vesicle trafficking, impacting the normal localization of olfactory signal transduction components and suppressing the activation of Olfr524. The inhibition is achieved through interference with the vesicular dynamics critical for olfactory signal transduction. | ||||||
D609 | 83373-60-8 | sc-201403 sc-201403A | 5 mg 25 mg | $189.00 $575.00 | 7 | |
Targets phosphatidylcholine-specific phospholipase C (PC-PLC), influencing membrane lipid composition and indirectly inhibiting Olfr524. D609 alters the lipid microenvironment, impacting olfactory receptor neuron function and hindering the activation of Olfr524. The inhibition is achieved through interference with the lipid dynamics critical for olfactory signal transduction. | ||||||